Antibiotic medicine | Total | Foundation Year 1 and 2 | All other prescribers | ||||||
---|---|---|---|---|---|---|---|---|---|
Rank | Observed | Percentage | Rank | Observed | Percentage | Rank | Observed | Percentage | |
Meropenem | 1 | 14 | 24.14% | 1 | 6 | 20.69% | 1 | 8 | 27.59% |
Tazocin | 2 | 11 | 18.97% | 2 | 5 | 17.24% | 2 | 6 | 20.69% |
Co-amoxiclav | 2 | 11 | 18.97% | 2 | 5 | 17.24% | 2 | 6 | 20.69% |
Flucloxacillin | 4 | 7 | 12.07% | 4 | 3 | 10.34% | 4 | 4 | 13.79% |
Metronidazole | 5 | 5 | 8.62% | 8 | 1 | 3.45% | 4 | 4 | 13.79% |
Doxycycline | 6 | 4 | 6.90% | 4 | 3 | 10.34% | 6 | 1 | 3.45% |
Clarithromycin | 7 | 2 | 3.45% | 6 | 2 | 6.90% | 7 | 0 | 0.00% |
Pyrazinamide | 7 | 2 | 3.45% | 6 | 2 | 6.90% | 7 | 0 | 0.00% |
Rifampicin | 9 | 1 | 1.72% | 8 | 1 | 3.45% | 7 | 0 | 0.00% |
Rifinah | 9 | 1 | 1.72% | 8 | 1 | 3.45% | 7 | 0 | 0.00% |
Total | 58 | 100% | 29 | 100% | 29 | 100% |